The global market for clostridium difficile diagnostics is estimated to expand as a result of the rising prevalence of clostridium difficile infection (CDI), which is predicted to increase the demand for its diagnosis. For instance, data from Cureus, an open access medical journal, released in December 2021 shows that C. difficile infection (CDI) affects 13 out of every 1,000 patients globally, with over 75% of cases being categorised as hospital acquired. Healthcare-associated CDI (HA-CDI) rates have been linked to higher rates of hospital admissions and antibiotic use. Increased morbidity and death have been associated with nosocomial CDI.
Additionally, over the course of the forecast period, regulatory agencies are anticipated to approve more diagnostic tests and assays. For instance, immunodiagnostics business Singulex, Inc. announced the commercial launch of their Clarity C. difftoxin A/B assay, a quick, sensitive, and accurate test for C. difficile toxin, in November 2018. The test has the potential to lessen false positives from polymerase chain reaction-based testing and false negatives from existing, less sensitive toxin immunoassays since it matches the sensitivity and specificity of cell cytotoxicity neutralisation assays.
The market for Clostridium Difficile Diagnostics is projected to reach US$ 838.05 million in 2022 and is anticipated to grow at a CAGR of 7.1% from 2022 to 2030.
Prominent Companies in the Clostridium Difficile Diagnostics Industry:
1. F. Hoffmann-La Roche Ltd: Tasmar's rights to production, marketing, and distribution in the United States and a few other non-European Union areas. Parkinson's illness is managed with the medication tasmar. United States headquarters. For $449 million, Roche buys the biotech company Inflazome.
2. Thermo Fisher Scientific: Thermo Fisher Scientific sells reagents for life sciences, laboratory supplies, and equipment for diagnostics. Founded 1956. United States headquarters.
3. Merck & Co., Inc.: The three primary business sectors of Merck KGaA are life sciences, performance materials, and healthcare. Researchers in academia and applied disciplines, such as the biopharmaceutical business, are supplied with laboratory supplies and equipment by the life sciences section. Established in 1891. German headquarters in Darmstadt. A legally binding deal has been struck by Merck to buy the chemical division of Mecaro Co. Ltd. (Mecaro), a publicly traded Korean manufacturer of heater blocks and chemical precursors for semiconductors.
4. Pfizer, Inc.: Pfizer Inc. is a pharmaceutical and biotechnology company based in America. It was founded in the year 1849. Pfizer manufactures and produces vaccines and medicine related to oncology, neurology, cardiology, and immunology. The corporation has produced various products that yield more than US$1 billion in annual revenue. The company ranked 64th on the Fortune 500 and 49th on the Forbes Global 2000. The headquarters are located in New York City, U.S. and the products manufactured are sold worldwide. The company was founded by Charles Pfizer and Charles F. Erhart. In 2022, the company acquired Arena Pharmaceuticals for US$ 6.7 Billion. In October 2022, Pfizer completed the acquisition Biohaven Pharma for US$ 11.6 Billion.
5. Abbott Laboratories: Abbott produces and sells branded generic pharmaceuticals, adult and paediatric nutritional items, diagnostic tools, and testing kits. Pacemakers, implanted cardioverter defibrillators, neuromodulation tools, coronary stents, catheters, baby formula, adult dietary liquids, molecular diagnostic platforms, immunoassays, and point-of-care diagnostic tools are among the products. Built in 1888. American headquarters in North Chicago. Recent Acquisitions: Cephea Valve Technologies (Jan 2019), JETi (Sep 2021), Cardiovascular Systems (Feb 2023).
6. Sanofi S.A.: Sanofi S.A. is a multinational pharmaceutical company that engages in the research and development, of pharmacological products, in the prescription market. The firm cover therapeutic areas like Cardiovascular, central nervous system, diabetes, internal medicine. The company was founded in 973 and the headquarters are located in Paris, France. Products manufactured include Medications, Genetic drugs, Vaccines, Animal Health, etc. December, 2022 Sanofi expanded its collaboration with Innate Pharma, with Sanofi licensing a natural killer (NK) cell nagger program targeting B7H3 from Innate’s ANKET platform.
7. Novartis AG,: Novartis AG is a Swiss pharmaceutical corporation founded in March 1996 by Johann Rudolf The headquarters are located in Basel Switzerland, Cambridge, The United States of America and Massachusetts. It is one of the largest Pharma based company incorporated. The drugs manufactured are sold worldwide. Total revenue earned as of 2022 is US 50.545 billion dollars. In June, 2022 Novartis completed the acquisition of Kedalion Therapeutics and its AcuStream technology.
*Definition: The simplest way to detect C. difficile is through a stool test, in which you provide a sample in a sterile container given to you at your doctor's office or a lab.
